EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access · CC BY 4.0

A flexible multi‐metric Bayesian framework for decision‐making in Phase II multi‐arm multi‐stage studies

Suzanne M Dufault iD, Angela M Crook, Katie Rolfe, Patrick P J Phillips

Statistics in Medicine · 2024

DOI: 10.1002/sim.9961 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Statistics in Medicine, 2024. Verfasst von Suzanne M Dufault und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biostatistics, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NIAID NIH HHS, Innovative Medicines Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We propose a multi‐metric flexible Bayesian framework to support efficient interim decision‐making in multi‐arm multi‐stage phase II clinical trials. Multi‐arm multi‐stage phase II studies increase the efficiency of drug development, but early decisions regarding the futility or desirability of a given arm carry considerable risk since sample sizes are often low and follow‐up periods may be short. Further, since intermediate outcomes based on biomarkers of treatment response are rarely perfect surrogates for the primary outcome and different trial stakeholders may have different levels of risk tolerance, a single hypothesis test is insufficient for comprehensively summarizing the state of the collected evidence. We present a Bayesian framework comprised of multiple metrics based on point estimates, uncertainty, and evidence towards desired thresholds (a Target Product Profile) for (1) ranking of arms and (2) comparison of each arm against an internal control. Using a large public‐private partnership targeting novel TB arms as a motivating example, we find via simulation study that our multi‐metric framework provides sufficient confidence for decision‐making with sample sizes as low as 30 patients per arm, even when intermediate outcomes have only moderate correlation with the primary outcome. Our reframing of trial design and the decision‐making procedure has been well‐received by research partners and is a practical approach to more efficient assessment of novel therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignHumansBayes TheoremSample SizeUncertaintyComputer Simulation

Stichwörter der Autor:innen

Bayesian methodsinterim analysismulti-arm multi-stagephase IItime to positivitytuberculosis

Autor:innen und Institutionen

  • Division of Biostatistics, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • UCSF Center for Tuberculosis, University of California, San Francisco, CA, USA.
  • MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.
  • GSK, Stevenage, UK.
  • Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, CA, USA.

ORCID-Profile: Suzanne M Dufault

Förderung

  • Medical Research Council
  • NIAID NIH HHS
  • Innovative Medicines Initiative
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Dufault, S. M., Crook, A. M., Rolfe, K., & Phillips, P. P. J. (2024). A flexible multi‐metric Bayesian framework for decision‐making in Phase II multi‐arm multi‐stage studies. Statistics in Medicine. https://doi.org/10.1002/sim.9961

Vancouver

Dufault SM, Crook AM, Rolfe K, Phillips PPJ. A flexible multi‐metric Bayesian framework for decision‐making in Phase II multi‐arm multi‐stage studies. Statistics in Medicine. 2024. doi:10.1002/sim.9961

BibTeX
@article{Dufault2024,
  author = {Dufault, Suzanne M and Crook, Angela M and Rolfe, Katie and Phillips, Patrick P J},
  title = {A flexible multi‐metric Bayesian framework for decision‐making in Phase II multi‐arm multi‐stage studies},
  journal = {Statistics in Medicine},
  year = {2024},
  doi = {10.1002/sim.9961}
}
Kostenlos starten →